K. Basu

发表

Evaluation of possible intramolecular [4+2] cycloaddition routes for assembling the central tetracyclic core of the potent marine antiinflammatory agent mangicol A

L. Paquette, Stefan Pichlmair, M. L. Ruiz, 2006 .

MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition

Lynn A. Hyde, Z. Yin, M. Kennedy, 2015, The Journal of Pharmacology and Experimental Therapeutics.

Pyrazoloquinolines as PDE10A inhibitors: discovery of a tool compound.

W. Greenlee, D. Tulshian, R. Hodgson, 2012, Bioorganic & medicinal chemistry letters.

Development of a Green and Sustainable Manufacturing Process for Gefapixant Citrate (MK-7264) Part 3: Development of a One-Pot Formylation–Cyclization Sequence to the Diaminopyrimidine Core

Nicholas J. Rogus, Rebecca A. Arvary, Michael A. Zompa, 2020 .

Comparative investigation of kinetic consequences associated with long-range electronic effects on catalytic ruthenium-promoted ring-closing metathesis

L. Paquette, K. Basu, J. Cabral, 2002 .

Evolution of the total synthesis of (-)-okilactomycin exploiting a tandem oxy-cope rearrangement/oxidation, a Petasis-Ferrier union/rearrangement, and ring-closing metathesis.

Amos B. Smith, K. Basu, T. Bosanac, 2009, Journal of the American Chemical Society.

Solution to the C3-Arylation of Indazoles: Development of a Scalable Method.

Rebecca T. Ruck, M. Poirier, K. Basu, 2016, Organic letters.

Total synthesis of (-)-okilactomycin.

Amos B. Smith, K. Basu, T. Bosanac, 2007, Journal of the American Chemical Society.

Total syntheses of the assigned structures of lituarines B and C.

M. Duffey, Amos B. Smith, K. Basu, 2008, Journal of the American Chemical Society.

Development of a stereoselective and scalable process for the preparation of a methylcyclobutanol-pyridyl ether.

L. Tan, M. Poirier, Eric Ashley, 2017, Bioorganic & medicinal chemistry.

Relative rate profile for ring-closing metathesis of a series of 1-substituted 1,7-octadienes as promoted by a 4,5-dihydroimidazol-2-ylidene-coordinated ruthenium catalyst.

Xin Guo, L. Paquette, K. Basu, 2003, Organic letters.

Development of a Green and Sustainable Manufacturing Process for Gefapixant Citrate (MK-7264) Part 1: Introduction and Process Overview

Wenjun Liu, Sachin Lohani, Hong Ren, 2020 .

Can We Make Small Molecules Lean? Optimization of a Highly Lipophilic TarO Inhibitor.

T. Roemer, S. Koseoglu, P. Tawa, 2017, Journal of medicinal chemistry.

Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity.

Marc Poirier, Michael W. Miller, Christian Mirescu, 2017, Journal of medicinal chemistry.

Enantiomer-Specific Oxygen-Exchange Reactions .2. Acid-Catalyzed Water Exchange with 1-Phenyl-1-Alkanols

M. Merritt, K. Basu, H. Cheon, 1994 .